2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Hypoglycemia: new trials by email Literature Review of Hypoglycemia trials Research Report on Hypoglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avexitide for Treatment of Post-Bariatric Hypoglycemia Avexitide, Placebo - Post Bariatric Hypoglycemia | Phase 3 | Active not recruiting | Amylyx Pharmaceuticals Inc. | 75 | 2025-04-29 | 2026-08-24 |
| RZ358 Treatment for Congenital Hyperinsulinism RZ358 (5 mg/kg) + SOC (Standard-of-Care) or Placebo + SOC, RZ358 (10 mg/kg) or Placebo + SOC, RZ358 (5-10 mg/kg) + SOC - Congenital Hyperinsulinism | Phase 3 | Active not recruiting | Rezolute | 56 | 2024-01-11 | 2026-01-08 |
Congenital Hyperinsulinism (1) · Digestive System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1) · Pancreatic Diseases (1)
Nutritional and Metabolic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Glucose Metabolism Disorders (1) · Infant, Newborn, Diseases (1) · Metabolic Diseases (1)
Standard of Care (1) · exendin (9-39) (1)
Amylyx Pharmaceuticals Inc. (1) · Rezolute (1)
United States (2) · Bulgaria (1) · Denmark (1) · France (1) · Georgia (1) · Germany (1) · Greece (1) · Oman (1) · Qatar (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · Vietnam (1)
Gopal Saha, MD (1)